Fed’s Goolsbee Warns Inflation Remains Elevated, Signals Caution on Rate Cuts 
Gold Prices Slip Amid Iran Tensions and Rising Rate Concerns 
Google Secures Pentagon AI Deal for Classified Projects 
US Stock Futures Rise as S&P 500 and Nasdaq Hit Record Highs Amid Earnings Optimism and Iran Tensions 
Dollar Holds Near Two-Week High as Fed Hawkish Shift Lifts Yields, Yen Near Intervention Zone 
US Stock Futures Mixed as Fed Holds Rates, Oil Prices Surge, and Big Tech Earnings Drive Market Moves 
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 
China Factory Activity Extends Growth in April Despite Global Pressures 
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth 
Oil Prices Surge Near $120 as U.S.-Iran Tensions Threaten Global Supply 
Asian Stock Markets Rise Amid Wall Street Rally and U.S.-Iran Tensions 
Oil Prices Surge Amid U.S.-Iran Tensions and Supply Disruption Fears 
Trump Rejects Iran Proposal as Tensions Persist Amid Fragile Ceasefire 
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings 
Wall Street Surges to Record Highs Amid Strong Earnings and Economic Stability 
Roche will be making big changes in the organization of its employees, which is estimated to be around 100,000 in number. The company is taking this step as it implements new prioritization of the works.
Announcement of change in the workforce
As part of the plans, Roche will be eliminating 300 to 400 jobs this year. The affected employees will be the ones working at the company’s product development sites.
According to Reuters, the news about job cuts was announced by Levi Garraway, the firm’s chief medical officer. Through a video call with the employees, he directly told them what the company is planning to do.
"We have made the difficult decision to reduce our workforce in PD by around five to seven percent by the end of the year," he said. "And that equates to somewhere between 300 to 400 roles that will be impacted globally."
The company knows that this is a big blow to the affected workers, so Roche will try to lessen the impact by working with employees. It was not mentioned, though, how the company intends to help those who are about to lose their position.
Who are set to lose their jobs
Based on the information shared, the Roche employees that will be cut from the company are those who are in the product development units and working in the area of project management, business management, administrative support, project delivery, managers, and posts in learning and development.
The product development sites that will cut workers are located in Canada, Britain, United States, Switzerland, and China. Those who will be laid off are set to be notified between the months of August and October, and British employees are the first ones to go.
Felix Arellano, Roche’s head of global drug safety, admitted that this is the hardest thing that he had to do since he started working for the company. He was referring to the fact that he has to send off colleagues as they have been eliminated by the company, as per Fierce Biotech.
Finally, while Roche is cutting jobs, some of the other major pharmaceutical companies are looking for more workers. Most are building new factories, so they need to hire hundreds of workers.
